To improve the diagnosis and treatment of patients with cardiovascular disease, Salinas Valley Memorial Healthcare System, an integrated healthcare network, wanted to create the Cardiovascular Diagnostic Center (CVDC) at its Ryan Ranch Outpatient facility in Monterey County, CA.


Buyer behavior and purchasing patterns evolve over time, particularly for capital equipment and information technology. What was important in the purchasing decision five or 10 years ago may not be today, as environmental, operational and technological changes impact the decision-making process.


In these challenging economic times, it’s important to make smart decisions when evaluating a 3D advanced visualization system in order to maximize your long-term investment. Budgets and staffing levels are decreasing, while the number of images and functional sophistication needed to analyze those images are increasing.



Many experts lauded multidetector computed tomography (MDCT) and cardiac computed tomography angiography (CCTA) as disruptive technologies that would abruptly alter the standard of care for those with coronary artery disease. Now, years later, CCTA is slowly gaining acceptance in the medical community, both by providers, payers and administrators. Why so slowly?



Imaging is playing an increasingly valuable role in all areas of radiation therapy as new image-guided techniques are used for tumor localization, treatment planning and verification of treatment plans. However, the resulting large volumes of image data are inundating radiation oncology information systems (OIMS), which are not equipped to efficiently store and retrieve data at this capacity.



While faster treatment delivery times are driving many radiation oncology clinicians to adopt volumetric modulated arc therapy (VMAT) as their technique of choice, others are holding steadfast to traditional intensity modulated radiation therapy (IMRT) systems.


May 14, 2009 - The FDA has cleared PhotoDetection Systems’ (PDS) NeuroPET scanner, a system designed to serve the clinical and research needs of the molecular neuro-imaging community.

May 14, 2009 - Nucletron, a knowledge-based leader in radiation oncology, today announced a new release of Oncentra Brachy, a comprehensive film- and volume-based treatment planning system to optimize cancer treatment planning for brachytherapy.

May 14, 2009 - The SNM Clinical Trials Network, an initiative designed to address the need for streamlined drug discovery through the integration of imaging biomarkers into multi-center clinical trials, recently added Genentech Inc. as a supporter.

May 14, 2009 -On May 8, 2009, CMS opened the reconsideration of the National Coverage Determination (NCD) on Positron Emission Tomography (FDG). The requestors have asked CMS to reconsider the NCD and broaden national coverage of FDG-PET (without CED restrictions) for the staging of cervical cancer (i.e.

Subscribe Now